DocketNumber: 1:10-vv-00039
Judges: Brian H. Corcoran
Filed Date: 8/21/2014
Status: Non-Precedential
Modified Date: 10/30/2014
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 10-39V ************************* * JONATHAN ELLIS and YAEL ELLIS, as * parents natural guardians of D.E., a minor, * * Filed: July 25, 2014 Petitioners, * * v. * * Decision by Stipulation; Damages SECRETARY OF HEALTH * Meningococcal Vaccine; Hepatitis A; AND HUMAN SERVICES, * Vaccine; Chronic Inflammatory * Demyelinating Polyneuropathy (CIDP) Respondent. * * ************************* Diana S. Sedar, Maglio, Christopher & Toale, Sarasota, FL, for Petitioners. Lisa A. Watts, U.S. Dep’t of Justice, Washington, DC, for Respondent. DECISION AWARDING DAMAGES 1 On January 20, 2010, Jonathan and Yael Ellis filed a petition on behalf of their minor child, D.E., seeking compensation under the National Vaccine Injury Compensation Program (“the Vaccine Program”). 2 Petitioners allege that D.E. suffered chronic inflammatory demyelinating polyneuropathy (“CIDP”) as a result of receiving the meningococcal and hepatitis A vaccines. 1 Because this decision contains a reasoned explanation for my action in this case, it will be posted on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205,116 Stat. 2899
, 2913 (codified as amended at44 U.S.C. § 3501
note (2006)). As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will be available to the public. (Id.) 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,100 Stat. 3755
, codified as amended, 42 U.S.C.A. ' 300aa-10-' 300aa-34 (West 1991 & Supp. 2002). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. ' 300aa. Respondent denies that D.E.’s CIDP or any other injury was caused by the receipt of the meningococcal and/or hepatitis A vaccines. Nonetheless both parties, while maintaining their above-stated positions, agreed in a stipulation filed July 25, 2014, that the issues before them can be settled, and that a decision should be entered awarding Petitioners compensation. I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein. The stipulation awards: a) A lump sum of $299,957.13, in the form of a check payable to petitioners as guardians/conservators of D.E.’s estate. This amount represents compensation for all damages that would be available under 42 U.S.C. §300aa-15(a). Stipulation ¶ 8. I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioners. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith. 3 IT IS SO ORDERED. /s/ Brian H. Corcoran Brian H. Corcoran Special Master 3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly (or separately) filing notice(s) renouncing their right to seek review.